Illumina to Grow Sales Staff by at Least Half in '06; Affy Suit Could Go to Court in Early March
 
Illumina’s global sales staff will increase by at least half this year as the company sets to roll out its BeadXpress molecular diagnostic platform, a company official said this week.
 
CEO Jay Flatley, speaking to investors at the UBS Global Life Sciences Conference in New York, said Illumina’s sales staff will grow by between 50 percent and 60 percent this year over last.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.